Medication Photo: Reuters Harvard study finds MedAware cuts prescription errors

The study analysed records from almost 800,000 patients in order to assess the efficacy of MedAware’s algorithm.

zami alberman Pluristem raises $15m, Can-Fite raises $5m

Pluristem recently announced the postponement of a $30 million investment agreement with a Chinese investor.

Kira Radinsky and Morris Kahn Photos: E.Yizhar, PR Predictive analytics health research institute set up

The Israeli institute has already developed technology for predicting colon cancer among Maccabi Health Fund patients.

Shufersal frozen vegetables Shufersal recalls frozen vegetables on listeria fears

The suspected presence of the bacteria was discovered in laboratory tests carried out after the product was already on the shelves.

Orcam Photo: PR Liberating the visually impaired

Israeli company OrCam has a discreet device that attaches to eyeglasses and reads aloud any text the wearer points to.

Teva  photo: PR Teva loses challenge to Eli Lilly cancer drug patent

The US Federal Court of Appeals upheld a lower court's decision on cancer treatment Alimta. 

Erez Vigodman  photo: Tamar Matsafi Chaim Hurvitz: Teva has no problem as a company

Some analysts see distress signals in Teva's 2017 outlook, but most still recommend "Buy".

Erez Vigodman photo: Eyal Yitzhar Teva strives to pull out of a tailspin

CEO Erez Vigodman retains the board's support even though the company's share has lost half its value.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2016